These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37704415)

  • 41. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.
    Pasquel FJ; Gianchandani R; Rubin DJ; Dungan KM; Anzola I; Gomez PC; Peng L; Hodish I; Bodnar T; Wesorick D; Balakrishnan V; Osei K; Umpierrez GE
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):125-133. PubMed ID: 27964837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review.
    Ojo O; Brooke J
    Nutrients; 2014 Nov; 6(11):5142-52. PubMed ID: 25412151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved Glucose Profile in Patients With Type 2 Diabetes With a New, High-Protein, Diabetes-Specific Tube Feed During 4 Hours of Continuous Feeding.
    Lansink M; Hofman Z; Genovese S; Rouws CHFC; Ceriello A
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):968-975. PubMed ID: 26826263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea.
    Sanz-París A; Calvo L; Guallard A; Salazar I; Albero R
    Nutrition; 1998; 14(11-12):840-5. PubMed ID: 9834926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
    Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
    BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal staffing for a good quality inpatient diabetes service.
    Dashora U; Flanagan D; Rayman G; Mustafa OG; Walden E; Dhatariya K;
    Diabet Med; 2023 Oct; 40(10):e15151. PubMed ID: 37328941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tube feeding with a diabetes-specific feed for 12 weeks improves glycaemic control in type 2 diabetes patients.
    Vaisman N; Lansink M; Rouws CH; van Laere KM; Segal R; Niv E; Bowling TE; Waitzberg DL; Morley JE
    Clin Nutr; 2009 Oct; 28(5):549-55. PubMed ID: 19501937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Basal insulin therapy strategy is superior to premixed insulin therapy in the perioperative period blood glucose management.
    Huang QX; Lou FC; Wang P; Liu Q; Wang K; Zhang L; Zhu L; Yu S; Xu H; Wang Q; Zhang Y; Hou WK
    Chin Med J (Engl); 2013 Nov; 126(21):4030-6. PubMed ID: 24229669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized.
    Nirantharakumar K; Marshall T; Kennedy A; Narendran P; Hemming K; Coleman JJ
    Diabet Med; 2012 Dec; 29(12):e445-8. PubMed ID: 22937877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoglycemia in Insulin-Treated Adults on Established Nasogastric Feeding in the General Ward: A Systematic Review.
    Vindedzis SA; Sherriff JL; Stanton KG
    Diabetes Educ; 2014 May; 40(3):290-298. PubMed ID: 24525570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
    Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
    Clin Ther; 2004 May; 26(5):724-36. PubMed ID: 15220016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
    Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
    Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit.
    Grainger A; Eiden K; Kemper J; Reeds D
    Nutr Clin Pract; 2007 Oct; 22(5):545-52. PubMed ID: 17906278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures.
    Seisa MO; Saadi S; Nayfeh T; Muthusamy K; Shah SH; Firwana M; Hasan B; Jawaid T; Abd-Rabu R; Korytkowski MT; Muniyappa R; Antinori-Lent K; Donihi AC; Drincic AT; Luger A; Torres Roldan VD; Urtecho M; Wang Z; Murad MH
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2139-2147. PubMed ID: 35690929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.
    Dickerson RN; Wilson VC; Maish GO; Croce MA; Minard G; Brown RO
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):506-16. PubMed ID: 22914894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.